Metraipolis › archive › dc_42cbd36969e2

GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40869064
DOI
10.3390/ijms26167744
License (as archived)
solo-consultazione
Archived
2026-11-10T18:03:25.185Z
SHA-256 of the archived text
94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b
Stable URL of this page
https://metraipolis.com/documento/dc_42cbd36969e2

How to cite

GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064 — Europe PMC (en), https://europepmc.org/article/MED/40869064 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42cbd36969e2 (Metraipolis archive dc_42cbd36969e2, sha256 94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b)
BibTeX
@misc{dc42cbd36969e2,
  title = {GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40869064},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42cbd36969e2; sha256 94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869064. Agents can read the archived copy with the MCP tool read_document.